iRadimed
IRMD
120 hedge funds and large institutions have $307M invested in iRadimed in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 7 closing their positions.
284% more call options, than puts
Call options by funds: $399K | Put options by funds: $104K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
43% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 37
13% more capital invested
Capital invested by funds: $271M → $307M (+$36M)
5% more funds holding
Funds holding: 114 → 120 (+6)
3% more ownership
Funds ownership: 48.23% → 51.22% (+3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCG
Resource Consulting Group
Orlando,
Florida
|
+$4.33M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$1.66M |
| 3 |
BlackRock
New York
|
+$1.61M |
| 4 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$1.18M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$909K |
| 2 |
SCM
SG Capital Management
Chicago,
Illinois
|
-$548K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$395K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$301K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$287K |
IRMD Hedge Fund Activity: Q4 2023 in Review
120 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2023, worth a combined $307M — up 13% from $271M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IRMD positions and 7 closed out — a net gain of 6 holders — while 53 added to existing stakes and 37 trimmed.
The largest buyer was Resource Consulting Group, opening a new position worth an estimated $4.33M. The largest seller was EAM Investors, exiting entirely with an estimated $909K sold.
- 120 institutional investors held iRadimed (IRMD) as of Q4 2023, up from 114 in Q3 2023.
- Funds reported $307M of iRadimed stock for Q4 2023, up 13% quarter-over-quarter.
- 13 funds opened new iRadimed positions in Q4 2023 and 7 closed out, a net change of +6 holders.
- The largest iRadimed buyer in Q4 2023 was Resource Consulting Group, an estimated $4.33M added.
- The largest iRadimed seller in Q4 2023 was EAM Investors, an estimated $909K sold.
Based on aggregated 13F filings for Q4 2023.